Fort Pitt Capital Group’s iShares Biotechnology ETF IBB Stock Holding History

Fort Pitt Capital Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-300	Closed	-$45K	–	223
2020 Q4	$45K	Buy	+300	New	+$42.9K	﹤0.01%	198

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fort Pitt Capital Group's IBB Position: Q1 2021 in Review

Fort Pitt Capital Group sold out of iShares Biotechnology ETF (IBB) in Q1 2021, closing a stake of 300 shares — an estimated $45K sold.

Fort Pitt Capital Group first reported a position in IBB in Q4 2020 and held it in 1 quarter. The position peaked at $45K in Q4 2020. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

Fort Pitt Capital Group reported no remaining iShares Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
Fort Pitt Capital Group sold 300 iShares Biotechnology ETF shares in Q1 2021, an estimated $45K.
Fort Pitt Capital Group first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 1 quarter.
Fort Pitt Capital Group's iShares Biotechnology ETF position peaked at $45K in Q4 2020.
845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on Fort Pitt Capital Group's 13F filing for Q1 2021, filed 16 Apr 2021.